Journal Article Ppublish 39 citations
PubMed: 36549172 DOI: 10.1016/j.ajp.2022.103409
Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge.
Asian J Psychiatr 80:103409
Authors: Danmei He, Minlan Yuan, Wen Dang, Lin Bai, Runnan Yang, Jingyi Wang, Yao Ma, Bo Liu, Shiyu Liu, Simai Zhang, Xiao Liao, Wei Zhang
Affiliations
- Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.
- Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China.
- Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
- West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.
- Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China.
Abstract
BACKGROUND
Emerging evidence shows that cognitive dysfunction may occur following coronavirus disease 19 (COVID-19) infection which is one of the most common symptoms reported in researches of "Long COVID". Several inflammatory markers are known to be elevated in COVID-19 survivors and the relationship between long-term inflammation changes and cognitive function remains unknown.
METHODS
We assessed cognitive function and neuropsychiatric symptoms of 66 COVID-19 survivors and 79 healthy controls (HCs) matched with sex, age, and education level using a digital, gamified cognitive function evaluation tool and questionnaires at 15 months after discharge. Venous blood samples were collected to measure cytokine levels. We performed correlation analyses and multiple linear regression analysis to identify the factors potentially related to cognitive function.
RESULTS
The COVID-19 survivors performed less well on the Trails (p = 0.047) than the HCs, but most of them did not report subjective neuropsychiatric symptoms. Intensive care unit experience (β = -2.247, p < 0.0001) and self-perceived disease severity (β = -1.522, p = 0.007) were positively correlated, whereas years of education (β = 0.098, p = 0.013) was negatively associated with the performance on the Trails. Moreover, the abnormally elevated TNF-α levels (r = -0.19, p = 0.040) were negatively correlated with performance on the Trails in COVID-19 group.
CONCLUSION
Our findings suggest that COVID-19 survivors show long-term cognitive impairment in executive function, even at 15 months after discharge. Serum TNF-α levels may be an underlying mechanism of long-term cognitive impairment in patients recovering from COVID-19.
MeSH
Cognitive Dysfunction, Signs And Symptoms, Covid-19, Cognition Disorders, Education, Cognition
Cited by
- Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage. Sci Rep, 2024
- Cognition and Memory after Covid-19 in a Large Community Sample. N Engl J Med, 2024
- Executive function deficit in patients with long COVID syndrome: A systematic review. Heliyon, 2025
- Psychometric properties of the COVID-19 Yorkshire Rehabilitation Scale: Post-Covid-19 syndrome in Iranian elderly population. BMC Infect Dis, 2024
- Cognitive and mental health trajectories of COVID-19: Role of hospitalisation and long-COVID symptoms. Eur Psychiatry, 2024
- Comments on "Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge". Asian J Psychiatr, 2023
- Neurocognitive Impairment in Long COVID: A Systematic Review. Arch Clin Neuropsychol, 2025
- Scientific Rationale for the Treatment of Cognitive Deficits from Long COVID. Neurol Int, 2023
- Infections with Chlamydia pneumoniae and SARS-CoV-2 and Alzheimer's disease pathogenesis. Front Aging Neurosci, 2025
- Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study. Brain Commun, 2024